-+ 0.00%
-+ 0.00%
-+ 0.00%

Rein Therapeutics holds annual shareholder meeting

PUBT·07/21/2026 20:12:22
Listen to the news
Rein Therapeutics holds annual shareholder meeting
  • Rein Therapeutics held its 2026 annual shareholder meeting on July 20, 2026.
  • Shareholders backed a charter amendment raising authorized common shares to 200 million from 100 million; the filing does not confirm implementation.
  • Shareholders ratified CBIZ CPAs as independent auditor for the year ending Dec. 31, 2026.
  • Two Class III directors were selected to serve through the 2029 annual meeting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rein Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-310315), on July 21, 2026, and is solely responsible for the information contained therein.